RE:RE:" Missing 18 Pending patients data"When reading that, oh man. Hope the smart folks on the board lends a few minutes to discuss it (I need to digest the talk tomorrow while at work, when the boss is not around). Mind-boggling if so many patients are left to influence the CR in a positive way. And there is nothing that points to them having much different outcome from those already done. I apologize if I have misunderstood the whole post. If not, well, I think I have to sell that damn kidney and load up with every cent left to spare. I mean if half of those still in waiting are CR, that should bring extremely happy days to shareholders. Hmm, perhaps that's why our CEO spoke of possible j/v talk late 2023 or beginning of 2024? There is simply a bit more time to pass until there are 25 optimized patients completed? I hope I have not unwillingly set myself up for disappointment now. I guess I can always blame my lack of English skill or low IQ. Made the day a bit more interesting at least.